Recent Advances and Current Role of Transperineal Prostate Biopsy - 18/11/20
Résumé |
“Approximately 1 million prostate biopsies are performed each year in the United States. This procedure has traditionally been performed using a transrectal approach, which is associated with a significant risk of infectious complications including sepsis. In recent years, transperineal prostate biopsy has been increasingly adopted due to its lower associated infectious risk. In this review, we explore the benefits of the transperineal approach for performing prostate biopsy and detail technical advancements that have allowed for this procedure to now be routinely performed in the outpatient settings under local anesthesia.”
Le texte complet de cet article est disponible en PDF.Keywords : Transperineal prostate biopsy, Infection, Sepsis, Transrectal prostate biopsy, Prostate cancer, MRI, Robot-assisted, Transrectal ultrasound
Plan
Conflicts of Interest: M.J. Allaway is the founder and CEO of Perineologic, a subsidiary of Corbin Clinical Resources, LLC. M.A. Gorin is a paid consultant for BK Medical ApS, KOELIS Inc., and Corbin Clinical Resources, LLC. |
Vol 48 - N° 1
P. 25-33 - février 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?